RT Journal Article
SR Electronic
A1 Parry, Nicola
T1 Combined Saxagliptin and Dapagliflozin Reduce Blood Glucose Levels in T2DM Patients
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 32
SP 10
OP 11
DO 10.1177/155989771432004
UL http://mdc.sagepub.com/content/14/32/10.abstract
AB This article presents results from the Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes trial [NCT01606007]. This active-controlled, double-blind, parallel-group phase 3 study demonstrated that combined saxagliptin and dapagliflozin, when added to metformin, were more effective in reducing glucose than treatment with metformin alone in adults with type 2 diabetes mellitus.